ARCHIVES

NCI Facing Extended Tie Under Acting Director – Maybe

This article is from The Cancer Letter archive.

Vol. 14 No. 34 | August 19, 1988

Download PDF Visit The Full Archive

Related Articles

Calif. Stem Cell Group To Collaborate With Canadians.

June 20, 2008

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 5, 1990

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

October 20, 1995

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004